Trial Profile
Comparison of Insulin glargine 300 U/ml + SGLT2 inhibitor therapy (Tofogliflozin 20 mg vs. Ipragliflozin 50 mg) using continuous glucose monitoring (CGM): randomised crossover study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2018
Price :
$35
*
At a glance
- Drugs Tofogliflozin (Primary) ; Insulin glargine; Ipragliflozin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 09 Mar 2017 Status changed from recruiting to completed.
- 24 Sep 2016 New trial record